Recognition of posterior scleritis and its treatment with indomethacin

Joseph Robertson

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Posterior scleritis is a rare disease, the clinical signs of which may vary. There is no consensus on the appropriate method of treatment for this disease. Some have advocated treatment with nonsteroidal antiinflammatory drugs, whereas others have reported variable success with potentially more toxic therapy. Patients with posterior scleritis constitute approximately 1% of the uveitis clinic population at the Casey Eye Institute in Portland, Oregon. The cases of 6 patients with posterior scleritis, the diagnosis of which was elusive, are reported. Posterior scleritis was generally confirmed by ultrasound examination. Each of the patients responded to treatment with indomethacin, which was usually the sole method of nontopical therapy. Thus, recognition of this relatively rare disease had marked implications for treatment.

Original languageEnglish (US)
Pages (from-to)17-21
Number of pages5
JournalRetina
Volume13
Issue number1
StatePublished - 1993

Fingerprint

Scleritis
Indomethacin
Rare Diseases
Therapeutics
Poisons
Uveitis
Anti-Inflammatory Agents
Pharmaceutical Preparations
Population

Keywords

  • Indomethacin
  • Nonsteroidal antiinflammatory drug
  • Scleritis
  • Ultrasound

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems

Cite this

Recognition of posterior scleritis and its treatment with indomethacin. / Robertson, Joseph.

In: Retina, Vol. 13, No. 1, 1993, p. 17-21.

Research output: Contribution to journalArticle

Robertson, J 1993, 'Recognition of posterior scleritis and its treatment with indomethacin', Retina, vol. 13, no. 1, pp. 17-21.
Robertson, Joseph. / Recognition of posterior scleritis and its treatment with indomethacin. In: Retina. 1993 ; Vol. 13, No. 1. pp. 17-21.
@article{53f92d4461674f13a0d12041ed5eab4a,
title = "Recognition of posterior scleritis and its treatment with indomethacin",
abstract = "Posterior scleritis is a rare disease, the clinical signs of which may vary. There is no consensus on the appropriate method of treatment for this disease. Some have advocated treatment with nonsteroidal antiinflammatory drugs, whereas others have reported variable success with potentially more toxic therapy. Patients with posterior scleritis constitute approximately 1{\%} of the uveitis clinic population at the Casey Eye Institute in Portland, Oregon. The cases of 6 patients with posterior scleritis, the diagnosis of which was elusive, are reported. Posterior scleritis was generally confirmed by ultrasound examination. Each of the patients responded to treatment with indomethacin, which was usually the sole method of nontopical therapy. Thus, recognition of this relatively rare disease had marked implications for treatment.",
keywords = "Indomethacin, Nonsteroidal antiinflammatory drug, Scleritis, Ultrasound",
author = "Joseph Robertson",
year = "1993",
language = "English (US)",
volume = "13",
pages = "17--21",
journal = "Retina",
issn = "0275-004X",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Recognition of posterior scleritis and its treatment with indomethacin

AU - Robertson, Joseph

PY - 1993

Y1 - 1993

N2 - Posterior scleritis is a rare disease, the clinical signs of which may vary. There is no consensus on the appropriate method of treatment for this disease. Some have advocated treatment with nonsteroidal antiinflammatory drugs, whereas others have reported variable success with potentially more toxic therapy. Patients with posterior scleritis constitute approximately 1% of the uveitis clinic population at the Casey Eye Institute in Portland, Oregon. The cases of 6 patients with posterior scleritis, the diagnosis of which was elusive, are reported. Posterior scleritis was generally confirmed by ultrasound examination. Each of the patients responded to treatment with indomethacin, which was usually the sole method of nontopical therapy. Thus, recognition of this relatively rare disease had marked implications for treatment.

AB - Posterior scleritis is a rare disease, the clinical signs of which may vary. There is no consensus on the appropriate method of treatment for this disease. Some have advocated treatment with nonsteroidal antiinflammatory drugs, whereas others have reported variable success with potentially more toxic therapy. Patients with posterior scleritis constitute approximately 1% of the uveitis clinic population at the Casey Eye Institute in Portland, Oregon. The cases of 6 patients with posterior scleritis, the diagnosis of which was elusive, are reported. Posterior scleritis was generally confirmed by ultrasound examination. Each of the patients responded to treatment with indomethacin, which was usually the sole method of nontopical therapy. Thus, recognition of this relatively rare disease had marked implications for treatment.

KW - Indomethacin

KW - Nonsteroidal antiinflammatory drug

KW - Scleritis

KW - Ultrasound

UR - http://www.scopus.com/inward/record.url?scp=0027447807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027447807&partnerID=8YFLogxK

M3 - Article

C2 - 8460274

AN - SCOPUS:0027447807

VL - 13

SP - 17

EP - 21

JO - Retina

JF - Retina

SN - 0275-004X

IS - 1

ER -